Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Pediatric Blood & Cancer|November 19, 2024
Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France ExperiencePablo Berlanga, Isabelle Aerts, Nadège Corradini, et al.The Lancet. Oncology|February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S Hong, Steven G DuBois, Shivaani Kummar, et al.Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.Journal of Experimental & Clinical Cancer Research : CR|May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade gliomaLisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.Nature Communications|August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibitionFemke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.Pageof 19